Overview

A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring

Status:
Completed

Trial end date:
2003-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the difference between tolterodine prolonged release (PR) and propiverine in efficacy as assessed by the AUM and to show that tolterodine PR is similar to propiverine with respect to micturition chart variables and safety profile.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Propiverine
Tolterodine Tartrate